Caveolin 3 (CAV3) (N-Term) 抗体

Caveolin 3 (CAV3) (N-Term) 抗体抗原
Caveolin 3 (CAV3)
别名 caveolin-3, cav-3, cav3, im:6902906, zgc:109710, LOC733765, CAV3, Cav-3, LGMD1C, LQT9, VIP-21, VIP21, AI385751, M-cav
抗原表位
其他选择 N-Term
适用
其他选择 犬, 小鼠, 大鼠, 牛, 猪, 人
宿主
其他选择 兔
克隆类型
多克隆
标记
其他选择 非结合性
应用范围
其他选择 免疫组织化学（IHC）, Western Blotting (WB)
Pubmed 找到1个引用
规格 50 μg
发货至 中国 (更改)
发货时间 9至12个工作日
产品编号 yb184201
产品细节 Caveolin 3 (CAV3) (N-Term) 抗体
免疫原 Synthetic peptide directed towards the N terminal of human CAV3
序列 MMAEEHTDLE AQIVKDIHCK EIDLVNRDPK NINEDIVKVD FEDVIAEPVG
预测反应 Bovine : 100 %, Human : 100 %, Pig : 90 %, Mouse : 80 %, Rat : 80 %
产品特性 This is a rabbit polyclonal antibody against CAV3. It was validated on Western Blot using a cell lysate as a positive control.
纯化方法 Affinity Purified
目标详细情况 Caveolin 3 (CAV3) (N-Term) 抗体
别名 CAV3
背景 CAV3 is a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites.
分子量 17 kDa
基因ID 859
NCBI登录号 NP_001225, NM_001234
UniProt P56539
使用细节 Caveolin 3 (CAV3) (N-Term) 抗体
应用备注 Optimal working dilutions should be determined experimentally by the investigator.
说明
Antigen size: 151 AA
限制 仅限研究用
贮存及处理 Caveolin 3 (CAV3) (N-Term) 抗体
状态 Lyophilized
溶解方式 Add 50 µL of distilled water.
浓度 1 mg/mL
缓冲液 PBS buffer with 2 % sucrose
注意事项 Avoid repeated freeze-thaw cycles.
储存条件 -20 °C
储存方法 For longer periods of storage, store at -20 °C